CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
Identifieur interne : 001076 ( PubMed/Checkpoint ); précédent : 001075; suivant : 001077CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
Auteurs : Peter W. Horby [Royaume-Uni] ; Karen L. Laurie [Australie] ; Benjamin J. Cowling [République populaire de Chine] ; Othmar G. Engelhardt [Royaume-Uni] ; Katharine Sturm-Ramirez [États-Unis] ; Jose L. Sanchez [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Timothy M. Uyeki [États-Unis] ; John Wood [Royaume-Uni] ; Maria D. Van Kerkhove [France]Source :
- Influenza and other respiratory viruses [ 1750-2659 ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Grippe humaine.
- épidémiologie : Grippe humaine.
- Humains, Pandémies, Plan de recherche, Études cas-témoins, Études de cohortes, Études séroépidémiologiques, Études transversales.
English descriptors
- KwdEn :
- MESH :
- epidemiology : Influenza, Human.
- immunology : Influenza, Human.
- prevention & control : Pandemics.
- statistics & numerical data : Pandemics.
- Case-Control Studies, Cohort Studies, Cross-Sectional Studies, Humans, Research Design, Seroepidemiologic Studies.
Abstract
Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting.
DOI: 10.1111/irv.12411
PubMed: 27417916
Affiliations:
- Australie, France, Royaume-Uni, République populaire de Chine, États-Unis
- Angleterre, Géorgie (États-Unis), Maryland, Oxfordshire, Victoria (État), Île-de-France
- Melbourne, Oxford, Paris
- Université d'Oxford
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27417916Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.</title><author><name sortKey="Horby, Peter W" sort="Horby, Peter W" uniqKey="Horby P" first="Peter W" last="Horby">Peter W. Horby</name><affiliation wicri:level="4"><nlm:affiliation>Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region><settlement type="city">Oxford</settlement></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author><author><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name><affiliation wicri:level="3"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infectious Diseases, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infectious Diseases, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region</wicri:regionArea><wicri:noRegion>Hong Kong Special Administrative Region</wicri:noRegion></affiliation></author><author><name sortKey="Engelhardt, Othmar G" sort="Engelhardt, Othmar G" uniqKey="Engelhardt O" first="Othmar G" last="Engelhardt">Othmar G. Engelhardt</name><affiliation wicri:level="1"><nlm:affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar</wicri:regionArea><wicri:noRegion>Potters Bar</wicri:noRegion></affiliation></author><author><name sortKey="Sturm Ramirez, Katharine" sort="Sturm Ramirez, Katharine" uniqKey="Sturm Ramirez K" first="Katharine" last="Sturm-Ramirez">Katharine Sturm-Ramirez</name><affiliation wicri:level="2"><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Sanchez, Jose L" sort="Sanchez, Jose L" uniqKey="Sanchez J" first="Jose L" last="Sanchez">Jose L. Sanchez</name><affiliation wicri:level="2"><nlm:affiliation>Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc, Silver Spring, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc, Silver Spring, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name><affiliation wicri:level="2"><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M" last="Uyeki">Timothy M. Uyeki</name><affiliation wicri:level="2"><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Wood, John" sort="Wood, John" uniqKey="Wood J" first="John" last="Wood">John Wood</name><affiliation wicri:level="1"><nlm:affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar</wicri:regionArea><wicri:noRegion>Potters Bar</wicri:noRegion></affiliation></author><author><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name><affiliation wicri:level="3"><nlm:affiliation>Center for Global Health, Institut Pasteur, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Center for Global Health, Institut Pasteur, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27417916</idno><idno type="pmid">27417916</idno><idno type="doi">10.1111/irv.12411</idno><idno type="wicri:Area/PubMed/Corpus">001279</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001279</idno><idno type="wicri:Area/PubMed/Curation">001268</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001268</idno><idno type="wicri:Area/PubMed/Checkpoint">001268</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001268</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.</title><author><name sortKey="Horby, Peter W" sort="Horby, Peter W" uniqKey="Horby P" first="Peter W" last="Horby">Peter W. Horby</name><affiliation wicri:level="4"><nlm:affiliation>Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region><settlement type="city">Oxford</settlement></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author><author><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name><affiliation wicri:level="3"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infectious Diseases, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infectious Diseases, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region</wicri:regionArea><wicri:noRegion>Hong Kong Special Administrative Region</wicri:noRegion></affiliation></author><author><name sortKey="Engelhardt, Othmar G" sort="Engelhardt, Othmar G" uniqKey="Engelhardt O" first="Othmar G" last="Engelhardt">Othmar G. Engelhardt</name><affiliation wicri:level="1"><nlm:affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar</wicri:regionArea><wicri:noRegion>Potters Bar</wicri:noRegion></affiliation></author><author><name sortKey="Sturm Ramirez, Katharine" sort="Sturm Ramirez, Katharine" uniqKey="Sturm Ramirez K" first="Katharine" last="Sturm-Ramirez">Katharine Sturm-Ramirez</name><affiliation wicri:level="2"><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Sanchez, Jose L" sort="Sanchez, Jose L" uniqKey="Sanchez J" first="Jose L" last="Sanchez">Jose L. Sanchez</name><affiliation wicri:level="2"><nlm:affiliation>Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc, Silver Spring, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc, Silver Spring, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name><affiliation wicri:level="2"><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M" last="Uyeki">Timothy M. Uyeki</name><affiliation wicri:level="2"><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Wood, John" sort="Wood, John" uniqKey="Wood J" first="John" last="Wood">John Wood</name><affiliation wicri:level="1"><nlm:affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar</wicri:regionArea><wicri:noRegion>Potters Bar</wicri:noRegion></affiliation></author><author><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name><affiliation wicri:level="3"><nlm:affiliation>Center for Global Health, Institut Pasteur, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Center for Global Health, Institut Pasteur, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Influenza and other respiratory viruses</title><idno type="eISSN">1750-2659</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Case-Control Studies</term><term>Cohort Studies</term><term>Cross-Sectional Studies</term><term>Humans</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Pandemics (prevention & control)</term><term>Pandemics (statistics & numerical data)</term><term>Research Design</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Grippe humaine (immunologie)</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Pandémies ()</term><term>Plan de recherche</term><term>Études cas-témoins</term><term>Études de cohortes</term><term>Études séroépidémiologiques</term><term>Études transversales</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term><term>Cohort Studies</term><term>Cross-Sectional Studies</term><term>Humans</term><term>Research Design</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Pandémies</term><term>Plan de recherche</term><term>Études cas-témoins</term><term>Études de cohortes</term><term>Études séroépidémiologiques</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27417916</PMID><DateCreated><Year>2016</Year><Month>08</Month><Day>09</Day></DateCreated><DateCompleted><Year>2017</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.</ArticleTitle><Pagination><MedlinePgn>2-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12411</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of the CONSISE ROSES-I statement was to improve the quality and transparency of reporting of influenza seroepidemiologic studies and facilitate the assessment of the validity and generalizability of published results.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The ROSES-I statement was developed as an expert consensus of the CONSISE epidemiology and laboratory working groups. The recommendations are presented in the familiar format of a reporting guideline. Because seroepidemiologic studies are a specific type of observational epidemiology study, the ROSES-I statement is built upon the STROBE guidelines. As such, the ROSES-I statement should be seen as an extension of the STROBE guidelines.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The ROSES-I statement presents 42 items that can be used as a checklist of the information that should be included in the results of published seroepidemiologic studies, and which can also serve as a guide to the items that need to be considered during study design and implementation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We hope that the ROSES-I statement will contribute to improving the quality of reporting of seroepidemiologic studies.</AbstractText><CopyrightInformation>© 2016 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Horby</LastName><ForeName>Peter W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laurie</LastName><ForeName>Karen L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infectious Diseases, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowling</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6297-7154</Identifier><AffiliationInfo><Affiliation>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelhardt</LastName><ForeName>Othmar G</ForeName><Initials>OG</Initials><AffiliationInfo><Affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturm-Ramirez</LastName><ForeName>Katharine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Jose L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc, Silver Spring, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Jacqueline M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyeki</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Kerkhove</LastName><ForeName>Maria D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Center for Global Health, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CONSISE Steering Committee</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/J008761/1</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>U01 GM110721</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM088558</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016446">Consensus Development Conference</PublicationType><PublicationType UI="D016431">Guideline</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2011 Aug 15;174(4):468-78</RefSource><PMID Version="1">21719743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2014 Jan 15;209(2):265-9</RefSource><PMID Version="1">23935201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2009 Nov 4;302(17 ):1880-7</RefSource><PMID Version="1">19822626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Mar 23;335(6075):1463</RefSource><PMID Version="1">22362880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Apr 22;9(4):e95612</RefSource><PMID Version="1">24755627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 1999 Apr;37(4):937-43</RefSource><PMID Version="1">10074505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol (Basel). 2003;115:63-73</RefSource><PMID Version="1">15088777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med Res Methodol. 2010 Mar 08;10:18</RefSource><PMID Version="1">20210985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2011 Dec;85(23):12455-63</RefSource><PMID Version="1">21957281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2013 May;56(9):1213-5</RefSource><PMID Version="1">23386632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2009 Nov 4;302(17 ):1872-9</RefSource><PMID Version="1">19822627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Euro Surveill. 2014 Jan 09;19(1):null</RefSource><PMID Version="1">24434176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2010 Jun 11;85(24):229-35</RefSource><PMID Version="1">20545056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2012 Jan 5;30(2):210-7</RefSource><PMID Version="1">22100887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Infect Dis. 2011 Nov;15(11):e781-6</RefSource><PMID Version="1">21855383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Mar 27;375(9720):1100-8</RefSource><PMID Version="1">20096450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Viral Immunol. 2011 Jun;24(3):221-6</RefSource><PMID Version="1">21668363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2012;8(12):e1003061</RefSource><PMID Version="1">23271967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Influenza Other Respir Viruses. 2017 Jan;11(1):2-14</RefSource><PMID Version="1">27417916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2010 Mar 24;7(3):e1000251</RefSource><PMID Version="1">20352064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol Methods. 2006 Mar;132(1-2):113-20</RefSource><PMID Version="1">16271401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011 Feb 23;6(2):e17074</RefSource><PMID Version="1">21373639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011 Mar 24;6(3):e17908</RefSource><PMID Version="1">21455307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2007 Oct 20;370(9596):1453-7</RefSource><PMID Version="1">18064739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Influenza Other Respir Viruses. 2013 May;7(3):231-4</RefSource><PMID Version="1">23280042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Nov 12;361(20):1945-52</RefSource><PMID Version="1">19745214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2011 Oct;8(10):e1001103</RefSource><PMID Version="1">21990967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Mar 27;375(9720):1062-3</RefSource><PMID Version="1">20096449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2009 Feb 3;6(2):e22</RefSource><PMID Version="1">19192942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2013 May;56(9):1206-12</RefSource><PMID Version="1">23386633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2014 Apr 03;10(4):e1004054</RefSource><PMID Version="1">24699693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Influenza Other Respir Viruses. 2013 Sep;7(5):872-86</RefSource><PMID Version="1">23331969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Emerg Infect Dis. 2009 Aug;15(8):1252-9</RefSource><PMID Version="1">19751587</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e48229</RefSource><PMID Version="1">23284613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</RefSource><PMID Version="1">20964521</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Influenza Other Respir Viruses. 2007 May;1(3):105-12</RefSource><PMID Version="1">19453415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2013 Aug 15;208(4):554-8</RefSource><PMID Version="1">23687225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiology. 2013 Nov;24(6):830-41</RefSource><PMID Version="1">24045719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(11):e26427</RefSource><PMID Version="1">22110586</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="Y">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>06</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27417916</ArticleId><ArticleId IdType="doi">10.1111/irv.12411</ArticleId><ArticleId IdType="pmc">PMC5155648</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>France</li><li>Royaume-Uni</li><li>République populaire de Chine</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Géorgie (États-Unis)</li><li>Maryland</li><li>Oxfordshire</li><li>Victoria (État)</li><li>Île-de-France</li></region><settlement><li>Melbourne</li><li>Oxford</li><li>Paris</li></settlement><orgName><li>Université d'Oxford</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Horby, Peter W" sort="Horby, Peter W" uniqKey="Horby P" first="Peter W" last="Horby">Peter W. Horby</name></region><name sortKey="Engelhardt, Othmar G" sort="Engelhardt, Othmar G" uniqKey="Engelhardt O" first="Othmar G" last="Engelhardt">Othmar G. Engelhardt</name><name sortKey="Wood, John" sort="Wood, John" uniqKey="Wood J" first="John" last="Wood">John Wood</name></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name></region></country><country name="République populaire de Chine"><noRegion><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name></noRegion></country><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Sturm Ramirez, Katharine" sort="Sturm Ramirez, Katharine" uniqKey="Sturm Ramirez K" first="Katharine" last="Sturm-Ramirez">Katharine Sturm-Ramirez</name></region><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name><name sortKey="Sanchez, Jose L" sort="Sanchez, Jose L" uniqKey="Sanchez J" first="Jose L" last="Sanchez">Jose L. Sanchez</name><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M" last="Uyeki">Timothy M. Uyeki</name></country><country name="France"><region name="Île-de-France"><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001076 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001076 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:27417916
|texte= CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27417916" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |